Karyopharm Initiates Registration-Directed Clinical Study of Selinexor (KPT-330) in Patients With Richter's Transformation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. QQQ

Go back to Karyopharm Initiates Registration-Directed Clinical Study of Selinexor (KPT-330) in Patients With Richter's Transformation
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 1.70 -0.02 (1.16%)
Previous Close $1.72    52 Week High $19.41 
Open $1.72    52 Week Low $4.83 
Day High $1.75    P/E N/A 
Day Low $1.65    EPS $-2.74 
Volume 615,727